The effect of parental smoking on lung function and development during infancy

Janet Stocks1, Carol Dezateux

  • 1Portex Anesthesia, Intensive Therapy and Respiratory Medicine Unit, Institute of Child Health, London, United Kingdom. j.stocks@ich.ucl.ac.uk

Respirology (Carlton, Vic.)
|October 8, 2003
PubMed

Insights

Parental smoking significantly impacts infant lung function, reducing airflow even before birth. Protecting infants from smoke exposure, both prenatally and postnatally, is crucial for healthy respiratory development.

Area of Science:

  • Pediatric pulmonology
  • Environmental health
  • Developmental biology

Background:

  • Parental smoking's adverse effects on childhood respiratory health are known.
  • The impact on early lung development, particularly during infancy, requires further clarification.
  • Distinguishing between prenatal and postnatal smoke exposure effects is challenging due to continued smoking post-pregnancy.

Purpose of the Study:

  • To review current evidence on parental smoking's effect on infant lung function.
  • To highlight the significance of both prenatal and postnatal smoke exposure.
  • To underscore the long-term implications of early lung development.

Main Methods:

  • Review of existing scientific literature on parental smoking and infant lung function.
  • Analysis of studies measuring lung function parameters in infants.
  • Examination of data differentiating prenatal and postnatal exposure effects.

Main Results:

  • Prenatal exposure to maternal smoking shows significant changes in infant tidal flow patterns.
  • A notable reduction (average 20%) in forced expiratory flows is observed in infants exposed to parental smoking.
  • Combined prenatal and postnatal exposure increases the risk of wheezing illnesses by two- to fourfold in the first year of life.

Conclusions:

  • Maternal smoking during pregnancy is a primary contributor to diminished infant airway function.
  • Postnatal smoke exposure elevates the risk of respiratory infections.
  • Maintaining a smoke-free environment for infants is essential for optimal lung development and future respiratory health.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...